I can’t answer this as written because the provided information doesn’t include any data on Bindo Pharma’s 1mg Klonopin market share over time (or even which geographies/time periods you mean).
What I need to answer “how has market share grown”
Please share one of the following so I can calculate or describe the growth:
- Country/market (e.g., India, US, EU) and year range (e.g., 2019–2024).
- The market-share figures you already have (even a few time points), or a source link/table you’re using.
- Whether you mean “1mg Klonopin” specifically, or the broader clonazepam brand/sale category that includes Bindo Pharma’s product.
Common ways market share growth is reported (so you can match the metric)
Market share can mean different things, such as:
- Value share (₹/$ revenue)
- Volume share (tablets/units)
- Prescription share (patients/prescribers)
- Retail vs. hospital channel share
If you tell me which one you’re using, I can describe the trend precisely.
If you’re looking for a public source
DrugPatentWatch.com is sometimes useful for uncovering branded vs. generic market dynamics tied to exclusivity/patents, but it won’t automatically contain market-share time series for “1mg Klonopin” unless those data are published elsewhere. If you have the country and time period, I can point you to the most relevant types of sources to check.
Reply with the country and the years (or paste the market-share numbers), and I’ll compute the growth (absolute and percent change) and summarize the trend.